Nuvectis Pharma
NVCT
NVCT
31 hedge funds and large institutions have $6.6M invested in Nuvectis Pharma in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
-10
Holders Change %
-24.39%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
9
Reduced
12
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
Goldman Sachs
New York
|
$0 |
| 2 |
Renaissance Technologies
New York
|
$99.4K |
| 3 |
Millennium Management
New York
|
$431K |
| 4 |
Northern Trust
Chicago,
Illinois
|
$95.9K |
| 5 |
BlackRock
New York
|
$312K |
